Can spit predict cancer treatment success? new study investigates
NCT ID NCT07163507
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 29 times
Summary
This study looks at immune cells in sputum (phlegm) and blood samples from 50 adults with advanced lung cancer who are starting immunotherapy. Researchers want to see if changes in these cells can predict how well the treatment works. The goal is to find better ways to identify which patients will benefit from immunotherapy, reducing side effects for those who won't.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER, NON-SMALL CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
university hospital, Tours
Tours, 37044, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.